| Bioactivity | Atogepant (MK-8031) is an orally active and selective calcitonin gene–related peptide receptor (CGRP) antagonist. Atogepant can be used for researching migraine[1]. | |||||||||
| Target | CGRP | |||||||||
| Name | Atogepant | |||||||||
| CAS | 1374248-81-3 | |||||||||
| Formula | C29H23F6N5O3 | |||||||||
| Molar Mass | 603.52 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Ailani J, et al. Atogepant for the Preventive Treatment of Migraine. N Engl J Med. 2021 Aug 19;385(8):695-706. |
Atogepant
CAS: 1374248-81-3 F: C29H23F6N5O3 W: 603.52
Atogepant (MK-8031) is an orally active and selective calcitonin gene–related peptide receptor (CGRP) antagonist. Atoge
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.